As of April 2024 Madrigal Pharmaceuticals has a market cap of $4.05 Billion. This makes Madrigal Pharmaceuticals the world's 2951th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $4.05 B | -11.24% |
2023 | $4.56 B | -11.79% |
2022 | $5.17 B | 257.45% |
2021 | $1.44 B | -15.74% |
2020 | $1.71 B | 22.31% |
2019 | $1.40 B | -19.07% |
2018 | $1.73 B | 33% |
2017 | $1.30 B | 657.54% |
2016 | $0.17 B | 255.44% |
2015 | $48.5 M | -83.23% |
2014 | $0.28 B | -35.25% |
2013 | $0.44 B | -28.17% |
2012 | $0.62 B | 168.97% |
2011 | $0.23 B | -10.26% |
2010 | $0.25 B | 49.82% |
2009 | $0.17 B | -17.18% |
2008 | $0.20 B | -8.54% |
2007 | $0.22 B |
On Apr 27th, 2024 the market cap of Madrigal Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.87 B | -78.34% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $20.9 M | -99.48% | ๐บ๐ธ USA |